NGF and Alzheimer disease: Nonetheless, the aggregate findings with regard to AD-associated proteins other than phospho-tau and AβPP-Aβ, suggest that assays of NGF, TGFbeta, aFGF, and possibly NTP in CSF or ventricular fluid could be employed in multi-biomarker panels for detecting AD or monitoring responses to therapy.